Maze Therapeutics, Inc. MAZE
We take great care to ensure that the data presented and summarized in this overview for Maze Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MAZE
Top Purchases
Top Sells
About MAZE
Insider Transactions at MAZE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 03
2025
|
Third Rock Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
950,800
+50.0%
|
-
|
|
Feb 03
2025
|
Third Rock Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Direct |
5,762,788
+48.69%
|
-
|
|
Feb 03
2025
|
Charles J Homcy |
BUY
Conversion of derivative security
|
Indirect |
7,422
+50.0%
|
-
|
|
Feb 03
2025
|
Charles J Homcy |
BUY
Conversion of derivative security
|
Direct |
29,524
+22.7%
|
-
|
|
Feb 03
2025
|
Jonathan E Lim |
BUY
Conversion of derivative security
|
Indirect |
307,956
+48.37%
|
-
|
Last 12 Months Summary
Buy / Acquisition
7.06M
Shares
From
3
Insiders
| Conversion of derivative security | 7.06M shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders